/
/
Velcade and Green Tea: A Myeloma No-No
Velcade and Green Tea: A Myeloma No-No image
Velcade and Green Tea: A Myeloma No-No
Posted Apr 11, 2022

Many of us myeloma patients have Velcade (bortezomib) as part of our treatment program, be it during induction, consolidation, or maintenance. There are plenty of companies/websites advertising the beneficial effects of green tea including “cancer prevention.” Just enter “green tea and cancer” in Google and you will find a near endless list of outfits ready to sell you green tea in a variety of forms.

However, a recent paper in the journal Advances in Clinical and Experimental Medicine reports on progress made in understanding the way green tea interacts with Velcade. There is no reason to go into the full detail of the science of the underlying mechanism of action between green tea and myeloma cell lines and the interaction with Velcade. There is, however, a reason to get right to the bottom line with the published conclusions:

“When bortezomib is involved in the multiple myeloma chemotherapy, the consumption of green tea should be avoided in order to maintain the biological efficacy of bortezomib.” [emphasis added]

The paper referenced above builds on prior research published in the journal Blood in 2009 that concluded:

“Taken together, our results indicate that green tea polyphenols may have the potential to negate the therapeutic efficacy of BZM and suggest that consumption of green tea products may be contraindicated during cancer therapy with BZM.” [emphasis added]

If you’d like to learn more about green tea you may wish to check out this website from Memorial Sloan Kettering Cancer Center in NYC that is very comprehensive and answers a wide variety of questions you may have. Under the section “Herb-Drug Interaction” you will find Velcade (bortezomib) with the warning:

“Bortezomib: EGCG and other polyphenols can inhibit the therapeutic effect of bortezomib and other boronic acid-based proteasome inhibitors.” [emphasis added]]

This last highlight is important because that would mean that combining green tea and treatment with Ninlaro (ixazomib) would also be a myeloma “no-no.” 

I cannot, however, find specific studies linking a negative interaction between Ninlaro and green tea. The second paper, referenced above, makes the comment, however, “This pronounced antagonistic function of EGCG was evident only with boronic acid-based proteasome inhibitors (BZM, MG-262, PS-IX), but not with several non-boronic acid proteasome inhibitors (MG-132, PS-I, nelfinavir). “

If you are a multiple myeloma patient on Ninlaro therapy and you consume green tea/green tea extract, then you may wish to consult with your physician and/or specialty pharmacist.

The author Paul Kleutghen

about the author
Paul Kleutghen

I am a patient diagnosed in 2014 with primary plasma cell leukemia (pPCL), a rare and aggressive variant of multiple myeloma and have been very fortunate to find treatment at the division of Cellular Therapy at the Duke University Cancer Institute. My wife, Vicki, and I have two adult children and a grandson who is the ‘light of my life’. Successful treatment has allowed Vicki and I to do what we love best : traveling the world, albeit it with some extra precautions to keep infections away. My career in the pharmaceutical industry has given me insights that I am currently putting to use as an advocate to lower drug pricing, especially prices for anti-cancer drugs and, very specifically, CAR-T therapies, with recent contributions posted by Health affairs, the Institute for Clinical and Economic Review and the Centers for Medicare and Medicaid Services.

More Life with Myeloma Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2021 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811